APR Reports a Larger Skin-Gloss Gain With Device and Cosmetic Use

On October 21, 2026, Seoul Economic Daily reported APR Corporation’s claim that pairing an electroporation home device with a cosmetic produced a greater improvement in skin radiance than the cosmetic alone. The report described a four-week comparison.

The useful starting point is the comparison itself: a device-and-cosmetic pairing versus cosmetics alone. Reading that distinction carefully helps separate an interesting cosmetic result from the broader claims that can gather around home beauty technology.

What did the device-and-cosmetic comparison measure?

The outcome behind the radiance language was skin gloss, according to the reporting. That is the measurement to keep in view when judging the finding.

“Radiance” can sound like a broad assessment of how healthy or refreshed skin looks. Skin gloss is a narrower outcome. A measured change in gloss should not be silently rewritten as improved skin health or a change in the biology of aging.

The comparison concerned the added contribution of a device when used alongside a cosmetic. Its central question was whether the combination produced a larger measured change than the cosmetic alone. Keeping that question intact makes the result easier to understand without adding claims the comparison was not designed to answer.

How should the reported percentages be read?

Seoul Economic Daily’s coverage described a larger reported improvement with combined use. The figures were:

• 16.4% improvement with the device and cosmetic together.
• 8.6% improvement with the cosmetic alone.

Both conditions showed reported improvement. The combination had the larger change, but the cosmetic-only result remains an important part of the finding. The comparison was not between a device-and-cosmetic routine and no skincare at all.

These figures describe changes in the measured outcome. They are not percentages of users who achieved a visible benefit. They also should not be read as a prediction of how much more radiant an individual reader’s skin would look.

Everyday use may differ from study conditions. The percentages therefore belong to this comparison, rather than to a guaranteed result from a home routine. The most useful reading preserves the outcome and its comparator instead of turning the larger figure into a standalone product promise.

What limits the interpretation of this result?

The short study period leaves durability unresolved. A change observed during the comparison does not establish how long it would last. The finding is also not proof of long-term safety.

The evidence is specific to the tested device and formulation. It does not establish that other electroporation devices or other cosmetics would produce the same result. It also cannot identify which individual ingredient contributed to the observed change.

Ingredient delivery is a separate question from cosmetic appearance. The reported percentage result does not demonstrate deeper delivery of a particular active ingredient. A gloss finding should therefore not become an ingredient-absorption claim simply because the two ideas appear together in product messaging.

Finally, this is a result presented by APR and covered in a news report. That reporting should be distinguished from manufacturer-independent confirmation. The company’s description of its finding is not itself that additional evidence step.

How can readers use the finding when assessing device claims?

The practical value is in reading the claim more precisely, not in treating it as a reason to change an individual skincare routine. A useful assessment keeps the comparison visible from the headline through to the conclusion.

When considering claims based on this report, three distinctions matter:

1. Keep the outcome attached to the number. The reported improvement concerns skin gloss. Broader language about rejuvenation or skin health would require evidence addressing those outcomes.
2. Keep the cosmetic-only comparison visible. The smaller reported improvement is part of the result. Omitting it makes the combined-use figure harder to interpret fairly.
3. Separate a research finding from a purchase decision. A larger measured change is relevant information. It does not establish whether a device is worthwhile or appropriate for a particular person.

For a broader discussion of how to assess claims made for skin devices, the same reading principle applies: identify the measured outcome before accepting a broader benefit statement.

The distinction also matters when evaluating topical products. Our discussion of reading a clinical study of topical peptides offers a related topic for readers interested in interpreting cosmetic research.

Personal questions about suitability belong with qualified care. This report is best used as information for that conversation rather than as an individual treatment recommendation.

What evidence should come next?

The finding sits within a wider business context. ChosunBiz has reported on APR’s expansion from cosmetics and home beauty devices toward medical-device products. That development describes a company’s direction, not the effectiveness of the pairing discussed here.

According to Seoul Economic Daily, APR said it plans to expand efficacy and safety verification of home beauty devices and cosmetics through its Global Dermatology Research Institute. That is a stated research intention. Its value will depend on the results that follow rather than on the announcement alone.

For now, the reported comparison provides a focused signal: the tested combination showed a larger skin-gloss change than the cosmetic alone. The next useful question is whether further research reproduces that benefit and establishes what the difference means for users.

Sources

1. APR Says Skin Glow Improves Nearly Twice as Much With Device and Cosmetics Combined
2. K-Beauty Firms Expand Into Hospital Medical Devices